Publications

Davies, SM; Ross, JA. Childhood cancer etiology: recent reports. Pediatric Blood and Cancer. 2003; 40:35-38.

ROSS, JA; DAVIES, SM; ROBISON, LL. Is it possible to catch leukaemia from a cat?. The Lancet. 1994; 344.

ROSS, JA; DAVIES, SM; POTTER, JD; ROBISON, LL. Epidemiology of childhood leukemia, with a focus on infants. Epidemiologic Reviews. 1994; 16:243-272.

DAVIES, SM. Maintenance of genomic imprinting at the IGF2 locus in hepatoblastoma. Cancer Research. 1993; 53:4781-4783.

Ramsay, NK; Davies, S. Bone marrow transplant for acute leukaemia. Best Practice and Research in Clinical Haematology. 1991; 4:483-510.

Rubinstein, JD; Lutzko, C; Leemhuis, T; Zhu, X; Pham, G; Ray, L; Thomas, S; Dourson, C; Wilhelm, J; Lane, A; et al. Scheduled administration of virus-specific T cells for viral prophylaxis after pediatric allogeneic stem cell transplant. Blood Advances. 2022; 6:2897-2907.

Powell, AW; Urbina, EM; Madueme, P; Rotz, S; Chin, C; Taylor, MD; Mays, WA; Davies, SM; Lane, A; Berger, S; et al. Abnormal Maximal and Submaximal Cardiopulmonary Exercise Capacity in Pediatric Stem Cell Transplant Recipients Despite Normal Standard Echocardiographic Parameters: A Pilot Study. Transplantation and cellular therapy. 2022; 28:263.e1-263.e5.

Sabulski, A; Grier, DD; Myers, KC; Davies, SM; Rubinstein, JD. Acute myeloid leukemia in SRP54‐mutated congenital neutropenia. 2022; 3:521-525.

Jodele, S; Dandoy, CE; Sabulski, A; Koo, J; Lane, A; Myers, KC; Wallace, G; Chima, RS; Teusink-Cross, A; Hirsch, R; et al. Transplantation-Associated Thrombotic Microangiopathy Risk Stratification: Is There a Window of Opportunity to Improve Outcomes?. Transplantation and cellular therapy. 2022.

Chihanga, T; Vicente-Muñoz, S; Ruiz-Torres, S; Pal, B; Sertorio, M; Andreassen, PR; Khoury, R; Mehta, P; Davies, SM; Lane, AN; et al. Head and Neck Cancer Susceptibility and Metabolism in Fanconi Anemia. Cancers. 2022; 14.

Mizuno, K; Dandoy, CE; Teusink-Cross, A; Davies, SM; Vinks, AA; Jodele, S. Eculizumab precision-dosing algorithm for thrombotic microangiopathy in children and young adults undergoing HSCT. Blood Advances. 2022; 6:1454-1463.

Gardner, JC; Courter, JD; Dandoy, CE; Davies, SM; Teusink-Cross, A. Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplantation Patients. Transplantation and cellular therapy. 2022; 28:167.e1-167.e5.

Rubinstein, JD; Krupski, MC; Khoury, R; Davies, SM; Norris, RE; Phillips, CL. 257 Significant Therapy Associated Toxicity Seen in Two Pediatric Survivors of Medulloblastoma Treated with Tisagenlecleucel for Relapsed Secondary B-Cell Acute Lymphoblastic Leukemia. Transplantation and cellular therapy. 2022; 28:s208-s209.

Fitch, TJ; Myers, KC; Davies, SM; Taggart, CB; Demmel, KM; Dandoy, CE. 179 Weight Loss after Hematopoietic Stem Cell Transplantation for Malignancy. Transplantation and cellular therapy. 2022; 28:s148-s149.

Sabulski, A; Arcuri, G; Szabo, S; Davies, SM; Jodele, S. 195 Neurologic Complications in Pediatric Transplant-Associated Thrombotic Microangiopathy. Transplantation and cellular therapy. 2022; 28.

Abdullah, S; Sabulski, A; Luebbering, N; Giordullo, L; Duell, A; Lake, KE; Laskin, B; Davies, SM. 50 Host Susceptibility to BK Polyomavirus Infection (BKPyV) and Hemorrhagic Cystitis (HC) in Children after Hematopoietic Cell Transplant (HCT). Transplantation and cellular therapy. 2022; 28:s42-s44.

Wang, YM; Abdullah, S; Luebbering, N; Duell, A; Lake, KE; Denson, LA; Jodele, S; Haslam, D; Faubion Jr., WA; Davies, SM; et al. 18 Alterations in Day+30 Intestinal Permeability As Measured By a Novel Lactulose:Rhamonose Test Predicts Adverse Outcomes in Children: A Prospective Study. Transplantation and cellular therapy. 2022; 28:s17-s18.

Gardner, J; Courter, J; Dandoy, CE; Davies, SM; Teusink-Cross, A. Safety and Efficacy of Prophylactic Levofloxacin in Pediatric and Adult Hematopoietic Stem Cell Transplant Patients. Transplantation and cellular therapy. 2022; 28.

Vasu, S; Bostic, M; Zhao, Q; Sharma, N; Puto, M; Knight, S; Scott, D; Guzman, R; Kromer, M; Tackett, K; et al. Acute GVHD, BK virus hemorrhagic cystitis and age are risk factors for transplant-associated thrombotic microangiopathy in adults. Blood Advances. 2022; 6:1342-1349.

Wang, YZ M; Teusink-Cross, A; Elborai, Y; Krupski, MC; Nelson, AS; Grimley, MS; Flannery, A; Mehta, PA; Bleesing, JJ; Chandra, S; et al. Ruxolitinib for the Treatment of Chronic GVHD and Overlap Syndrome in Children and Young Adults. Transplantation. 2022; 106:412-419.

Rubinstein, JD; Jodele, S; Heyenbruch, D; Wilhelm, J; Thomas, S; Lutzko, C; Zhu, X; Leemhuis, T; Cancelas, JA; Keller, M; et al. Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation Recipients. Transplantation and cellular therapy. 2022; 28:116.e1-116.e7.

Odegard, EA; Meeds, HL; Kleiboeker, SB; Ziady, A; Sabulski, A; Jodele, S; Seif, AE; Davies, SM; Laskin, BL; Blackard, JT. BK Polyomavirus Subtypes II and IV in Hematopoietic Cell Transplant Recipients. Microbiology Resource Announcements. 2022; 11.

Furutani, E; Liu, S; Galvin, A; Steltz, S; Malsch, MM; Loveless, SK; Mount, L; Larson, JH; Queenan, K; Bertuch, AA; et al. Hematologic complications with age in Shwachman-Diamond syndrome. Blood Advances. 2022; 6:297-306.

Chandra, S; Mizuno, K; Zhao, J; Davies, SM; Marsh, RA; Fukuda, T; Setchell, KD R; Vinks, AA; Mehta, PA. Test-dose pharmacokinetics guided melphalan dose adjustment in reduced intensity conditioning allogeneic transplant for non-malignant disorders. British Journal of Clinical Pharmacology. 2022; 88:115-127.

Odegard, EA; Meeds, HL; Kleiboeker, SB; Ziady, A; Sabulski, A; Jodele, S; Seif, AE; Davies, SM; Laskin, BL; Blackard, JT. Optimized amplification of BK polyomavirus in urine. Journal of Virological Methods. 2022; 299.

Wang, YZ M; Gloude, NJ; Davies, SM; Lucky, AW; Nelson, AS. Reply to: Comment on: Hematopoietic stem cell transplant for erythropoietic porphyrias in pediatric patients. Pediatric Blood and Cancer. 2022; 69.

Kennedy, AL; Myers, KC; Bowman, J; Gibson, CJ; Camarda, ND; Furutani, E; Muscato, GM; Klein, RH; Ballotti, K; Liu, S; et al. Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome. Nature Communications. 2021; 12.

Walkup, LL; Myers, KC; Willmering, MM; Mehta, PA; Nelson, AS; Fleck, RJ; Woods, JC; Davies, SM; Towe, CT. Modern Lung Magnetic Resonance Imaging to Screen for Pulmonary Complications in Patients with Dyskeratosis Congenita. American Journal of Respiratory and Critical Care Medicine. 2021; 204:1340-1343.

Arnold, DE; Emoto, C; Fukuda, T; Dong, M; Vinks, AA; Lane, A; McIntosh, K; Neumeier, L; Lankester, AC; Achini, F; et al. A prospective pilot study of a novel alemtuzumab target concentration intervention strategy. Bone Marrow Transplantation. 2021; 56:3029-3031.

Sabulski, A; Myers, KC; Bleesing, JJ; Duell, A; Lane, A; Teusink-Cross, A; Davies, SM; Jodele, S. Graft rejection markers in children undergoing hematopoietic cell transplant for bone marrow failure. Blood Advances. 2021; 5:4594-4604.

Davies, SM. Grasping the sword of Damocles. Blood. 2021; 138:1792-1793.

Wallace, G; Rosen, N; Towbin, AJ; Jodele, S; Myers, KC; Davies, SM; Flannery, A; Gurria, JP. Pneumatosis intestinalis after hematopoietic stem cell transplantation: When not doing anything is good enough. Journal of Pediatric Surgery. 2021; 56:2073-2077.

Koo, J; Teusink-Cross, A; Davies, SM; Jodele, S; Dandoy, CE. Single-center results reporting improved hematopoietic stem cell mobilization success in pediatric and young adult patients with solid tumors and lymphoma. Pediatric Blood and Cancer. 2021; 68.

Rubinstein, JD; Zhu, X; Leemhuis, T; Pham, G; Ray, L; Emberesh, S; Jodele, S; Thomas, S; Cancelas, JA; Bollard, CM; et al. Virus-specific T cells for adenovirus infection after stem cell transplantation are highly effective and class II HLA restricted. Blood Advances. 2021; 5:3309-3321.

McGrady, ME; Mara, CA; Geiger-Behm, K; Ragsdale, J; Davies, SM; Schwartz, LA; Phipps, S; Pai, AL H. Psychometric evaluation of the brief RCOPE and relationships with psychological functioning among caregivers of children undergoing hematopoietic stem cell transplant. Psycho-Oncology. 2021; 30:1457-1465.

Khandelwal, P; Teusink-Cross, A; Kumar, AR; Bleesing, JJ; Mehta, PA; Jordan, MB; Chandra, S; Davies, SM; Marsh, RA. Daratumumab for the management of autoimmune cytopenias in children and young adults: a case series. British Journal of Haematology. 2021; 194:e84-e89.

Wang, YZ M; Gloude, NJ; Davies, SM; Lucky, AW; Nelson, AS. Hematopoietic stem cell transplant for erythropoietic porphyrias in pediatric patients. Pediatric Blood and Cancer. 2021; 68.

Levine, JE; Grupp, SA; Pulsipher, MA; DIetz, AC; Rives, S; Myers, GD; August, KJ; Verneris, MR; Buechner, J; Laetsch, TW; et al. Pooled safety analysis of tisagenlecleucel in children and young adults with B cell acute lymphoblastic leukemia. Journal for ImmunoTherapy of Cancer. 2021; 9.

Ibrahimova, A; Davies, SM; Lane, A; Jordan, MB; Lake, K; Litts, B; Chaturvedi, V; Owsley, E; Myers, KC; Nelson, AS; et al. α4β7 Integrin expression and blockade in pediatric and young adult gastrointestinal graft-versus-host disease. Pediatric Blood and Cancer. 2021; 68.

Sabulski, A; Szabo, S; Myers, KC; Davies, SM; Jodele, S. Testicular thrombotic microangiopathy: An unrecognized complication. Pediatric Blood and Cancer. 2021; 68.

Dandoy, CE; Davies, SM; Ahn, KW; He, Y; Kolb, AE; Levine, J; Bo-Subait, S; Abdel-Azim, H; Bhatt, N; Chewing, J; et al. Comparison of total body irradiation versus non-total body irradiation containing regimens for de novo acute myeloid leukemia in children. Haematologica. 2021; 106:1839-1845.

Gershgorin, I; Waldron, ER; Grupp, SA; Levine, JE; Pulsipher, MA; Davies, SM; Myers, GD; Jeschke, M; Engels, B; del Corral, C; et al. Abstract 510: Impact of tisagenlecleucel product attributes on clinical outcomes in pediatric and young adult patients with relapsed or refractory acute lymphoblastic leukemia (r/r ALL). Cancer Research. 2021; 81:510-510.

Jung, M; Mehta, PA; Jiang, CS; Rosti, RO; Usleaman, G; da Rosa, JM C; Lach, FP; Goodridge, E; Auerbach, AD; Davies, SM; et al. Comparison of the clinical phenotype and haematological course of siblings with Fanconi anaemia. British Journal of Haematology. 2021; 193:971-975.

Kumar, S; Nattamai, KJ; Hassan, A; Amoah, A; Karns, R; Zhang, C; Liang, Y; Shimamura, A; Florian, MC; Bissels, U; et al. Repolarization of HSC attenuates HSCs failure in Shwachman-Diamond syndrome. Leukemia. 2021; 35:1751-1762.

Wallace, G; Khandelwal, P; Myers, KC; Perentesis, EM R; Lane, A; Teusink-Cross, A; Smiley, K; Davies, SM; Jodele, S. Prospective pilot trial of calcipotriene as a novel topical treatment for acute skin graft versus host disease. Bone Marrow Transplantation. 2021; 56:1441-1444.

Ryan, TD; Moore, RA; Lang, SM; Khoury, P; Dandoy, CE; Davies, SM; Taylor, MD. Rapid cardiac MRI protocol for cardiac assessment in paediatric and young adult patients undergoing haematopoietic stem cell transplant: a feasibility study. Cardiology in the Young. 2021; 31:973-978.

Luebbering, N; Abdullah, S; Lounder, D; Lane, A; Dole, N; Rubinstein, J; Hewison, M; Gloude, N; Jodele, S; Perentesis, KM R; et al. Endothelial injury, F-actin and vitamin-D binding protein after hematopoietic stem cell transplant and association with clinical outcomes. Haematologica. 2021; 106:1321-1329.

Wang, YZ M; Howell, JC; Grimley, MS; Lane, A; Davies, SM; Myers, KC. Incidence of thyroid dysfunction in children after HSCT with reduced intensity conditioning (RIC) or myeloablative conditioning (MAC). Pediatric Transplantation. 2021; 25.

Stefanski, KJ; Anixt, JS; Goodman, P; Bowers, K; Leisenring, W; Scott Baker, K; Burns, K; Howell, R; Davies, S; Robison, LL; et al. Long-Term Neurocognitive and Psychosocial Outcomes After Acute Myeloid Leukemia: A Childhood Cancer Survivor Study Report. Journal of the National Cancer Institute. 2021; 113:481-495.

Khandelwal, P; Yeh, RF; Yu, L; Lane, A; Dandoy, CE; El-Bietar, J; Davies, SM; Grimley, MS. Graft-versus-host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft-versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta-thalassemia Major With Busulfan, Fludarabine, and Thiotepa. Transplantation. 2021; 105:891-896.

Sauter, SL; Zhang, X; Romick-Rosendale, L; Wells, SI; Myers, KC; Brusadelli, MG; Poff, CB; Brown, DR; Panicker, G; Unger, ER; et al. Human Papillomavirus Oral- and Sero- Positivity in Fanconi Anemia. Cancers. 2021; 13.

Ruiz-Torres, S; Brusadelli, MG; Witte, DP; Wikenheiser-Brokamp, KA; Sauter, S; Nelson, AS; Sertorio, M; Chlon, TM; Lane, A; Mehta, PA; et al. Inherited DNA Repair Defects Disrupt the Structure and Function of Human Skin. Cell Stem Cell. 2021; 28:424-435.e6.

Tamburro, RF; Cooke, KR; Davies, SM; Goldfarb, S; Hagood, JS; Srinivasan, A; Steiner, ME; Stokes, D; DiFronzo, N; El-Kassar, N; et al. Pulmonary Complications of Pediatric Hematopoietic Cell Transplantation. A National Institutes of Health Workshop Summary. Annals of the American Thoracic Society. 2021; 18:381-394.

Sabulski, A; Davies, SM; Paulsen, G; Marsh, R; Chandra, S. BCG-osis and Hematopoietic Cell Transplant for Primary Immunodeficiencies. Journal of Clinical Immunology. 2021; 41:491-494.

Odegard, EA; Meeds, HL; Kleiboeker, SB; Ziady, A; Sabulski, A; Jodele, S; Davies, SM; Laskin, BL; Blackard, JT. BK Polyomavirus Genotypes in Two Patients after Hematopoietic Cell Transplant. Microbiology Resource Announcements. 2021; 10.

Dandoy, CE; Rotz, S; Alonso, PB; Klunk, A; Desmond, C; Huber, J; Ingraham, H; Higham, C; Dvorak, CC; Duncan, C; et al. A pragmatic multi-institutional approach to understanding transplant-associated thrombotic microangiopathy after stem cell transplant. Blood Advances. 2021; 5:1-11.

Bartlett, AL; Romick-Rosendale, L; Nelson, A; Abdullah, S; Luebbering, N; Bartlett, J; Brusadelli, M; Palumbo, JS; Lake, K; Litts, B; et al. Tryptophan metabolism is dysregulated in individuals with Fanconi anemia. Blood Advances. 2021; 5:250-261.

Chandra, S; Chandrakasan, S; Dávila Saldaña, BJ; Bleesing, JJ; Jordan, MB; Kumar, AR; Grimley, MS; Krupski, C; Davies, SM; Khandelwal, P; et al. Experience with a Reduced Toxicity Allogeneic Transplant Regimen for Non-CGD Primary Immune Deficiencies Requiring Myeloablation. Journal of Clinical Immunology. 2021; 41:89-98.

Laskin, BL; Denburg, MR; Furth, SL; Moatz, T; Altrich, M; Kleiboeker, S; Lutzko, C; Zhu, X; Blackard, JT; Jodele, S; et al. The Natural History of BK Polyomavirus and the Host Immune Response After Stem Cell Transplantation. Clinical Infectious Diseases. 2020; 71:3044-3054.

Nelson, AS; Heyenbruch, D; Rubinstein, JD; Sabulski, A; Jodele, S; Thomas, S; Lutzko, C; Zhu, X; Leemhuis, T; Cancelas, JA; et al. Virus-specific T-cell therapy to treat BK polyomavirus infection in bone marrow and solid organ transplant recipients. Blood Advances. 2020; 4:5745-5754.

Reddy, P; Davies, S; Majhail, N; Sandmaier, B; Hari, P; Cutler, C. In response to "American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults ". Blood Advances. 2020; 4:5431-5432.

Rubinstein, JD; Krupski, C; Nelson, AS; O'Brien, MM; Davies, SM; Phillips, CL. Chimeric Antigen Receptor T Cell Therapy in Patients with Multiply Relapsed or Refractory Extramedullary Leukemia. Biology of Blood and Marrow Transplantation. 2020; 26:e280-e285.

Sabulski, A; Davies, SM; Paulsen, G; Kumar, A; Grimley, M; Chandra, S. Non-Tuberculous Mycobacterial Infection in Hematopoietic Cell Transplant. Journal of Clinical Immunology. 2020; 40:1171-1175.

Davies, SM; Jordan, MB; Marsh, R. A tribute to the life and work of Alexandra (Lisa) H. Filipovich, 1951-2020. Pediatric Blood and Cancer. 2020; 67.

Badia, P; Andersen, H; Haslam, D; Nelson, AS; Pate, AR; Golkari, S; Teusink-Cross, A; Flesch, L; Bedel, A; Hickey, V; et al. Improving Oral Health and Modulating the Oral Microbiome to Reduce Bloodstream Infections from Oral Organisms in Pediatric and Young Adult Hematopoietic Stem Cell Transplantation Recipients: A Randomized Controlled Trial. Biology of Blood and Marrow Transplantation. 2020; 26:1704-1710.

Khandelwal, P; Fukuda, T; Teusink-Cross, A; Kashuba, AD M; Lane, A; Mehta, PA; Marsh, RA; Jordan, MB; Grimley, MS; Myers, KC; et al. CCR5 inhibitor as novel acute graft versus host disease prophylaxis in children and young adults undergoing allogeneic stem cell transplant: results of the phase II study. Bone Marrow Transplantation. 2020; 55:1552-1559.

Rubinstein, JD; Zhu, X; Lutzko, C; Leemhuis, T; Cancelas, JA; Jodele, S; Bollard, CM; Hanley, PJ; Davies, SM; Grimley, MS; et al. Complement inhibition does not impair the clinical antiviral capabilities of virus-specific T-cell therapy. Blood Advances. 2020; 4:3252-3257.

Erez, DL; Denburg, MR; Afolayan, S; Jodele, S; Wallace, G; Davies, SM; Seif, AE; Bunin, N; Laskin, BL; Sullivan, KE. Acute Kidney Injury in Children after Hematopoietic Cell Transplantation Is Associated with Elevated Urine CXCL10 and CXCL9. Biology of Blood and Marrow Transplantation. 2020; 26:1266-1272.

Blackard, JT; Davies, SM; Laskin, BL. BK polyomavirus diversity-Why viral variation matters. Reviews in Medical Virology. 2020; 30.

Phillips, CL; Lane, A; Gerbing, RB; Alonzo, TA; Wilkey, A; Radloff, G; Lange, B; Gamazon, ER; Dolan, ME; Davies, SM. Genomic Variants of Cytarabine Sensitivity Associated with Treatment-Related Mortality in Pediatric AML: A Report from the Children's Oncology Group. Clinical Cancer Research. 2020; 26:2891-2897.

Stark, JE; Opoka, AM; Fei, L; Zang, H; Davies, SM; Wong, HR; Alder, MN. Longitudinal characterization of olfactomedin-4 expressing neutrophils in pediatric patients undergoing bone marrow transplantation. PLoS ONE. 2020; 15.

Teusink-Cross, A; Davies, SM; Grimley, MS; Chandra, S; Flannery, A; Dandoy, CE; Nelson, AS; Marsh, RA; Jacoby, B; Lane, A; et al. Ibrutinib for the treatment of chronic graft-vs-host disease in pediatric hematopoietic stem cell transplant patients: A single-center experience. Pediatric Transplantation. 2020; 24.

Rubinstein, JD; Nelson, AS; Krupski, C; O'Brien, W; Taylor, JM; Badgett, TC; Huang, M; Davies, SM; Phillips, CL. Chimeric antigen receptor T-cell therapy in patients with neurologic comorbidities. Pediatric Blood and Cancer. 2020; 67.

Davies, SM; Iannone, R; Alonzo, TA; Wang, YC; Gerbing, R; Soni, S; Kolb, EA; Meshinchi, S; Orchard, PJ; Burns, LJ; et al. A Phase 2 Trial of KIR-Mismatched Unrelated Donor Transplantation Using in Vivo T Cell Depletion with Antithymocyte Globulin in Acute Myelogenous Leukemia: Children's Oncology Group AAML05P1 Study. Biology of Blood and Marrow Transplantation. 2020; 26:712-717.

Jodele, S; Dandoy, CE; Lane, A; Laskin, BL; Laskin, B; Teusink-Cross, A; Myers, KC; Wallace, G; Nelson, AS; Nelson, A; et al. Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab. Blood. 2020; 135:1049-1057.

Jodele, S; Medvedovic, M; Luebbering, N; Chen, J; Dandoy, CE; Laskin, BL; Davies, SM. Interferon-complement loop in transplant-associated thrombotic microangiopathy. Blood Advances. 2020; 4:1166-1177.

Myers, KC; Furutani, E; Weller, E; Siegele, B; Galvin, A; Arsenault, V; Alter, BP; Boulad, F; Bueso-Ramos, C; Burroughs, L; et al. Clinical features and outcomes of patients with Shwachman-Diamond syndrome and myelodysplastic syndrome or acute myeloid leukaemia: a multicentre, retrospective, cohort study. The Lancet Haematology. 2020; 7:e238-e246.

Rubinstein, JD; Burns, K; Absalon, M; Lutzko, C; Leemhuis, T; Chandra, S; Hanley, PJ; Keller, MD; Davies, SM; Nelson, A; et al. EBV-directed viral-specific T-lymphocyte therapy for the treatment of EBV-driven lymphoma in two patients with primary immunodeficiency and DNA repair defects. Pediatric Blood and Cancer. 2020; 67.

Gloude, NJ; Dandoy, CE; Davies, SM; Myers, KC; Jordan, MB; Marsh, R; Kumar, A; Bleesing, JJ; Teusink-Cross, A; Jodele, S. Thinking Beyond HLH: Clinical Features of Patients with Concurrent Presentation of Hemophagocytic Lymphohistiocytosis and Thrombotic Microangiopathy. Biology of Blood and Marrow Transplantation. 2020; 26:s15-s16.

Sabulski, A; Aunins, B; Abdullah, S; Luebbering, N; Davies, SM. Circulating Endothelial Cells As a Marker of Vascular Injury in Pediatric Patients. Biology of Blood and Marrow Transplantation. 2020; 26:s144-s145.

Khandelwal, P; Chaturvedi, V; Owsley, E; Lane, A; Heyenbruch, D; Lutzko, CM; Leemhuis, T; Grimley, MS; Nelson, AS; Davies, SM; et al. CD38brightCD8+ T Cells Associated with the Development of Acute GVHD Are Activated, Proliferating, and Cytotoxic Trafficking Cells. Biology of Blood and Marrow Transplantation. 2020; 26:1-6.

Davies, SM. Monitoring and treatment of MDS in genetically susceptible persons. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2019; 2019:105-109.

Mehta, PA; Emoto, C; Fukuda, T; Seyboth, B; Teusink-Cross, A; Davies, SM; Wilhelm, J; Fuller, K; Vinks, AA; Boulad, F. Busulfan Pharmacokinetics and Precision Dosing: Are Patients with Fanconi Anemia Different?. Biology of Blood and Marrow Transplantation. 2019; 25:2416-2421.

Broglie, L; Fretham, C; Al-Seraihy, A; George, B; Kurtzberg, J; Loren, A; MacMillan, M; Martinez, C; Davies, SM; Pasquini, MC. Pulmonary Complications in Pediatric and Adolescent Patients Following Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 2019; 25:2024-2030.

Benoit, SW; Dixon, BP; Goldstein, SL; Bennett, MR; Lane, A; Lounder, DT; Rotz, SJ; Gloude, NJ; Lake, KE; Litts, B; et al. A novel strategy for identifying early acute kidney injury in pediatric hematopoietic stem cell transplantation. Bone Marrow Transplantation. 2019; 54:1453-1461.

Badia, P; Hickey, V; Flesch, L; Byerly, M; Sensibaugh, C; Potts, K; Michel, C; Drozd, A; Curd, F; Crosby, L; et al. Quality Improvement Initiative to Reduce Nighttime Noise in a Transplantation and Cellular Therapy Unit. Biology of Blood and Marrow Transplantation. 2019; 25:1844-1850.

Benoit, SW; Goldstein, SL; Dahale, DS; Haslam, DB; Nelson, A; Truono, K; Davies, SM. Reduction in Nephrotoxic Antimicrobial Exposure Decreases Associated Acute Kidney Injury in Pediatric Hematopoietic Stem Cell Transplant Patients. Biology of Blood and Marrow Transplantation. 2019; 25:1654-1658.

Pai, AL H; Swain, AM; Chen, FF; Hwang, W; Vega, G; Carlson, O; Ortiz, FA; Canter, K; Joffe, N; Kolb, EA; et al. Screening for Family Psychosocial Risk in Pediatric Hematopoietic Stem Cell Transplantation with the Psychosocial Assessment Tool. Biology of Blood and Marrow Transplantation. 2019; 25:1374-1381.

Taggart, C; Neumann, N; Alonso, PB; Lane, A; Pate, A; Stegman, A; Stendahl, A; Davies, SM; Dandoy, CE; Grimley, M. Comparing a Neutropenic Diet to a Food Safety-Based Diet in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 2019; 25:1382-1386.

Sampson, M; Hickey, V; Huber, J; Alonso, PB; Davies, SM; Dandoy, CE. Feasibility of continuous temperature monitoring in pediatric immunocompromised patients: A pilot study. Pediatric Blood and Cancer. 2019; 66.

Walkup, LL; Myers, K; El-Bietar, J; Nelson, A; Willmering, MM; Grimley, M; Davies, SM; Towe, C; Woods, JC. Xenon-129 MRI detects ventilation deficits in paediatric stem cell transplant patients unable to perform spirometry. European Respiratory Journal. 2019; 53.

Ballard, DW; Kuppermann, N; Vinson, DR; Tham, E; Hoffman, JM; Swietlik, M; Davies, SJ D; Alessandrini, EA; Tzimenatos, L; Bajaj, L; et al. Implementation of a Clinical Decision Support System for Children With Minor Blunt Head Trauma Who Are at Nonnegligible Risk for Traumatic Brain Injuries. Annals of Emergency Medicine. 2019; 73:440-451.

Khandelwal, P; Andersen, H; Romick-Rosendale, L; Taggart, CB; Watanabe, M; Lane, A; Dandoy, CE; Lake, KE; Litts, BA; Morrow, AL; et al. A Pilot Study of Human Milk to Reduce Intestinal Inflammation After Bone Marrow Transplant. Breastfeeding Medicine. 2019; 14:193-202.

Rotz, SJ; Powell, A; Myers, KC; Taylor, MD; Jefferies, JL; Lane, A; El-Bietar, JA; Davies, SM; Dandoy, CE; Ryan, TD. Treatment exposures stratify need for echocardiographic screening in asymptomatic long-term survivors of hematopoietic stem cell transplantation. Cardiology in the Young. 2019; 29:338-343.

Andersen, H; Dandoy, CE; Alonso, PB; Blum, S; Frenck, R; Danziger-Isakov, L; Davies, SM; Haslam, D. Development of an Infection Risk Index for Microbiome Targeted Intervention in Children at High-Risk of Multidrug-Resistant Bloodstream Infections. Biology of Blood and Marrow Transplantation. 2019; 25:s73-s74.

Kapadia, M; Dandoy, CE; Jordan, MB; Davies, SM; Myers, KC. CD34+ Selected Hematopoietic Transplant, an Option When Compliance Is a Concern in Pediatric Patients. Biology of Blood and Marrow Transplantation. 2019; 25:s204-s205.

Loveless, M; Minar, P; Stark, J; Alder, MN; Luebbering, N; Myers, KC; Lake, KE; Litts, B; Davies, SM; Khandelwal, P. Soluble CD64 Is a Novel Marker of Steroid Refractory Acute Gastrointestinal Graft Versus Host Disease in Pediatric Allogeneic Hematopoietic Stem Cell Transplant. Biology of Blood and Marrow Transplantation. 2019; 25:s258-s259.

Towe, C; Gloude, NJ; Grimley, MS; Foster, K; Mount, L; Davies, SM; Myers, KC. Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant Have Reduced Six-Minute Walk Test Distance and Results Predict Transplant Outcomes. Biology of Blood and Marrow Transplantation. 2019; 25.

Bartlett, AL; Nelson, AS; Goodridge, E; Mehta, PA; Davies, SM; Myers, KC. Late Effects Following Hematopoietic Stem Cell Transplant with Busulfan-Based Preparative Regimen in Fanconi Anemia. Biology of Blood and Marrow Transplantation. 2019; 25:s69-s70.

Benoit, SW; Nelson, AS; Dixon, BP; Bennett, M; Davies, SM. Urinary Biomarkers of Acute Kidney Injury in Pediatric Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 2019; 25.

Alonso, PB; Andersen, H; Haslam, D; Nelson, AS; El-Bietar, J; Pate, AR; Golkari, S; Teusink-Cross, A; Flesch, L; Bedel, A; et al. Modulation of the Oral Microbiome to Improve Oral Health and Reduce BSI from Oral Flora in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Randomized Controlled Trial. Biology of Blood and Marrow Transplantation. 2019; 25:s88-s89.

Alonso, PB; Andersen, H; Haslam, D; Flesch, L; Kramer, K; Zimmerman, E; Ruehlmann, K; Demmel, KM; Sellers, A; Stevenson, J; et al. Scrubbing the Hub, How Long Is Enough?. Biology of Blood and Marrow Transplantation. 2019; 25:s367-s368.

Erez, DL; Sullivan, KE; Denburg, M; Bunin, NJ; Jodele, S; Afolayan, S; Wallace, G; Davies, SM; Laskin, B. Urinary CXCL10 and CXCL9 Are Associated with Acute Kidney Injury in Children after Hematopoietic Stem Cell Transplantation: Results of a Discovery and Validation Cohort. Biology of Blood and Marrow Transplantation. 2019; 25:s185-s186.

Teusink-Cross, A; Davies, SM; Grimley, MS; Chandra, S; Dandoy, CE; Jacoby, B; Khandelwal, P. Ibrutinib for the Treatment of Chronic Graft Versus Host Disease in Pediatric Patients. Biology of Blood and Marrow Transplantation. 2019; 25:s93-s94.

Khandelwal, P; Porollo, A; Davies, SM; Haslam, D; Andersen, H. Changes in the Stool Virome and Fungome of Children Undergoing Bone Marrow Transplant. Biology of Blood and Marrow Transplantation. 2019; 25.

Laskin, B; Denburg, M; Lowery, A; Saycocie, P; Altrich, M; Kleiboeker, S; Jodele, S; Lutzko, C; Zhu, X; Duell, A; et al. A Prospective Multi-Center Study of the Natural History of BK Viremia and Host Immune Response in Children after Allogeneic Hematopoietic Cell Transplant. Biology of Blood and Marrow Transplantation. 2019; 25.

Khandelwal, P; Davies, SM; Jordan, MB; Lake, KE; Litts, B; Owsley, E; Marsh, RA. α4β7 Integrin Is Upregulated on CD8+ Effector Memory T-Cells in Children with Gut Gvhd Prior to Clinical Symptoms and Represents a Therapeutic Target in Pediatric Allogeneic HSCT Patients. Biology of Blood and Marrow Transplantation. 2019; 25:s265-s266.

Dagnall, CL; Morton, LM; Hicks, BD; Li, S; Zhou, W; Karlins, E; Teshome, K; Chowdhury, S; Lashley, KS; Sampson, JN; et al. Successful use of whole genome amplified DNA from multiple source types for high-density Illumina SNP microarrays. BMC Genomics. 2018; 19.

Romick-Rosendale, LE; Haslam, DB; Lane, A; Denson, L; Lake, K; Wilkey, A; Watanabe, M; Bauer, S; Litts, B; Luebbering, N; et al. Antibiotic Exposure and Reduced Short Chain Fatty Acid Production after Hematopoietic Stem Cell Transplant. Biology of Blood and Marrow Transplantation. 2018; 24:2418-2424.

Grossmann, L; Alonso, PB; Nelson, A; El-Bietar, J; Myers, KC; Lane, A; Andersen, H; Haslam, D; Jodele, S; Davies, SM; et al. Multiple bloodstream infections in pediatric stem cell transplant recipients: A case series. Pediatric Blood and Cancer. 2018; 65.

Apewokin, S; Andersen, HM; Medlin, S; Mersha, T; Weiss, A; Haslam, D; Davies, SM. 1574. Cancer Chemotherapy May Induce Acquisition of Antibiotic Resistance Genes in Antibiotic-Naïve Cancer Patients. Open Forum Infectious Diseases. 2018; 5:s491-s491.

Hickey, V; Flesch, L; Lane, A; Pai, AL H; Huber, J; Badia, P; Davies, SM; Dandoy, CE. Token economy to improve adherence to activities of daily living. Pediatric Blood and Cancer. 2018; 65.

Wall, SA; Zhao, Q; Yearsley, M; Blower, L; Agyeman, A; Ranganathan, P; Yang, S; Wu, H; Bostic, M; Jaglowski, S; et al. Complement-mediated thrombotic microangiopathy as a link between endothelial damage and steroid-refractory GVHD. Blood Advances. 2018; 2:2619-2628.

Jodele, S; Dandoy, CE; Myers, K; Wallace, G; Lane, A; Teusink-Cross, A; Weiss, B; Davies, SM. High-dose Carboplatin/Etoposide/Melphalan increases risk of thrombotic microangiopathy and organ injury after autologous stem cell transplantation in patients with neuroblastoma. Bone Marrow Transplantation. 2018; 53:1311-1318.

Orlando, EJ; Han, X; Tribouley, C; Wood, PA; Leary, RJ; Riester, M; Levine, JE; Qayed, M; Grupp, SA; Boyer, M; et al. Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia. Nature Medicine. 2018; 24:1504-1506.

Wallace, G; Jodele, S; Myers, KC; Dandoy, CE; El-Bietar, J; Nelson, A; Teusink-Cross, A; Khandelwal, P; Taggart, C; Gordon, CM; et al. Single Ultra-High-Dose Cholecalciferol to Prevent Vitamin D Deficiency in Pediatric Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 2018; 24:1856-1860.

Du, W; Liu, W; Mizukawa, B; Shang, X; Sipple, J; Wunderlich, M; Geiger, H; Davies, S; Mulloy, J; Pang, Q; et al. A non-myeloablative conditioning approach for long-term engraftment of human and mouse hematopoietic stem cells. Leukemia. 2018; 32:2041-2046.

Tillery, R; Joffe, NE; Mara, CA; Davies, SM; Pai, AL H. Longitudinal examination of family efficacy following pediatric stem cell transplant. Psycho-Oncology. 2018; 27:1915-1921.

Chandra, S; Fukuda, T; Mizuno, K; Davies, SM; Teusink-Cross, A; Tarin, R; Marsh, RA; Vinks, AA; Mehta, PA. Micafungin antifungal prophylaxis in children undergoing HSCT: can we give higher doses, less frequently? A pharmacokinetic study. Journal of Antimicrobial Chemotherapy. 2018; 73:1651-1658.

Wallace, G; Myers, KC; Teusink-Cross, A; Davies, SM; Khandelwal, P; Jodele, S. Topical vitamin D analog for chronic graft versus host disease of the skin. Bone Marrow Transplantation. 2018; 53:628-633.

Coleman, K; Flesch, L; Petiniot, L; Pate, A; Lin, L; Crosby, L; Beebe, DW; Nelson, A; Alonso, PB; Davies, SM; et al. Sleep disruption in caregivers of pediatric stem cell recipients. Pediatric Blood and Cancer. 2018; 65.

Damen, A; Heyenbruch, D; Gong, N; Maurer, K; Grimley, M; Nelson, A; Davies, S; Lutzko, C; Zhu, X; Bollard, C; et al. 294 Production of quadrivalent virus-specific t cells utilizing peptide stimulation. Cytotherapy. 2018; 20:s99-s100.

Davies, SM. Human Milk to Prevent and Heal Gastrointestinal Tract Injury in Children After Bone Marrow Transplantation. Breastfeeding Medicine. 2018; 13:S18-S19.

Kanj, RV; Nelson, AS; Myers, KC; Mehta, PA; Davies, SM; Goodridge, E; Phillips, K; Hemphill, Z; Hoefgen, HR. Gynecologic and Reproductive Concerns in Patients With Fanconi Anemia. Journal of Pediatric and Adolescent Gynecology. 2018; 31.

Toro, HO-D; Howell, JC; Badia, P; Benoit, J; Davies, S; Grimley, M; Jodele, S; Phillips, C; Burns, K; Khandelwal, P; et al. Reduced Fertility Potential in Young Patients Following Hematopoietic Stem Cell Transplantation Despite Reduced Intensity Conditioning. Journal of Pediatric and Adolescent Gynecology. 2018; 31.

Toro, HO-D; Howell, JC; Badia, P; Benoit, J; Davies, SM; Grimley, MS; Jodele, S; Phillips, C; Burns, K; Khandelwal, P; et al. 88 Reduced Fertility Potential in Young Patients Following Hematopoietic Stem Cell Transplantation Despite Reduced Intensity Conditioning. Biology of Blood and Marrow Transplantation. 2018; 24:s89-s90.

Nelson, AS; Teusink-Cross, A; Chandra, S; Mehta, PA; Leemhuis, T; Grimley, MS; Kumar, A; Jordan, MB; Myers, KC; Davies, SM. 605 HSCT for Pediatric Patients with Severely Reduced Renal Function. Biology of Blood and Marrow Transplantation. 2018; 24.

Urbanski, A; Sper, C; Bonavita, A; Fohl, D; Leemhuis, T; Mehta, PA; Myers, KC; Davies, SM; Nelson, AS. 600 Increased CD34 Cell Dose is Associated with Rapid Immune Reconstitution after HSCT in Patients with Fanconi Anemia. Biology of Blood and Marrow Transplantation. 2018; 24:s435-s436.

Nelson, AS; Heyenbruch, D; Damen, A; Gong, N; Maurer, K; Zhu, X; Wilhelm, J; Fohl, D; Sper, C; Bonavita, A; et al. 89 Building a Third-Party VST Bank From Scratch—the Cincinnati Experience. Biology of Blood and Marrow Transplantation. 2018; 24.

Laskin, B; Seif, AE; Bunin, NJ; Wang, Y; Beier, U; Altrich, M; Kleiboeker, S; Jodele, S; Davies, SM; Denburg, M. 85 BK Viremia is Common in Children after Allogeneic Hematopoietic Cell Transplant. Biology of Blood and Marrow Transplantation. 2018; 24.

Luebbering, N; Alder, MN; Davies, SM. 602 Increased Expression of Stem Cell Marker Olfactomedin-4 in Gastrointestinal Graft-Versus-Host Disease. Biology of Blood and Marrow Transplantation. 2018; 24.

Jodele, S; Luebbering, N; Medvedovic, M; Chen, J; Davies, SM. 597 Complement and Interferon Pathway Activation Triggers Thrombotic Microangiopathy after Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 2018; 24.

Chandra, S; Bleesing, JJ; Jordan, MB; Grimley, MS; Khandelwal, P; Davies, SM; Edwards, S; Leemhuis, T; Marsh, RA. 596 Post-Transplant CD34+ Selected Stem Cell “Boost” as Intervention for Mixed Chimerism Following Reduced Intensity Conditioning HSCT in Children and Young Adults with Primary Immune Deficiencies. Biology of Blood and Marrow Transplantation. 2018; 24:s433-s434.

Luebbering, N; Lounder, DT; Davies, SM. 591 Functional Studies of Elevated Vitamin D Binding Protein after Stem Cell Transplant. Biology of Blood and Marrow Transplantation. 2018; 24:s429-s430.

Badia, P; Andersen, H; Haslam, D; Nelson, AS; El-Bietar, J; Pate, AR; Golkari, S; Teusink-Cross, A; Flesch, L; Bedel, A; et al. 587 Impact of Xylitol on Oral Microbiome and Blood Stream Infections in HSCT Recipients. Biology of Blood and Marrow Transplantation. 2018; 24:s427-s428.

Flesch, L; Hayward, M; Koons, C; Coleman, KM; Hickey, V; Jodele, S; Davies, SM; Dandoy, CE. 382 Sustained Reduction in Cardiac Monitor Alarms in a Pediatric Bone Marrow Transplant Unit. Biology of Blood and Marrow Transplantation. 2018; 24.

Heyenbruch, D; Damen, A; Gong, N; Maurer, K; Grimley, MS; Nelson, AS; Davies, SM; Lutzko, C; Zhu, X; Bollard, CM; et al. 186 Production of Trivalent Antigen-Specific T Cells Utilizing Viral Peptide Stimulation. Biology of Blood and Marrow Transplantation. 2018; 24:s172-s173.

Pai, AL H; Rausch, J; Drake, S; Morrison, CF; Lee, JL; Nelson, A; Tackett, A; Berger, S; Szulczewski, L; Mara, C; et al. Poor Adherence Is Associated with More Infections after Pediatric Hematopoietic Stem Cell Transplant. Biology of Blood and Marrow Transplantation. 2018; 24:381-385.

Khoury, R; Sauter, S; Kovacic, MB; Nelson, AS; Myers, KC; Mehta, PA; Davies, SM; Wells, SI. Risk of Human Papillomavirus Infection in Cancer-Prone Individuals: What We Know. Viruses. 2018; 10.

Doss, LM; Dandoy, CE; Kramer, K; Pate, A; Flesch, L; El-Bietar, J; Lane, A; Davies, SM; Thikkurissy, S. Oral health and hematopoietic stem cell transplantation: A longitudinal evaluation of the first 28 days. Pediatric Blood and Cancer. 2018; 65.

Daniels, P; Pate, A; Flesch, L; Teusink-Cross, A; Matani, H; Geiger, A; Hayward, M; Myers, W; Schaefer, S; Nelson, A; et al. Improving Time to Antibiotic Administration for Bone Marrow Transplant Patients With First Fever. Pediatrics. 2018; 141.